Across TCGA pan-cancer cohorts, FAM74A3 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated FAM74A3 data layer.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher FAM74A3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM74A3 expression acts as an unfavorable survival marker, although some lineages such as PAAD and CHOL show a favorable association.
ACC, LGG, and UCEC are the cancer types where FAM74A3 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.